The Combined Application of PARP Inhibitor and PD-1/PD-L1 Inhibitor in the Treatment of Ovarian Cancer

GUO Jing-jing; ZHANG Yun-feng; WANG Yue

doi:10.12280/gjfckx.20230289

Home>Articles>The Combined Application of PARP Inhibitor and PD-1/PD-L1 Inhibitor in the Treatment of Ovarian Cancer

DOI: 10.12280/gjfckx.20230289

The Combined Application of PARP Inhibitor and PD-1/PD-L1 Inhibitor in the Treatment of Ovarian Cancer

GUO Jing-jing

ZHANG Yun-feng

WANG Yue

Keywords：Ovarian neoplasmsImmunotherapyMolecular targeted therapyPoly (ADP-ribose) polymerase inhibitorsImmune checkpoint inhibitorsPD-1/PD-L1 inhibitor

Publication Date：2023-10-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 568-572 )

Journal Of International Obstetrics And Gynecology

ISTIC

ISSN：1674-1870

Year, Vol.(Issue)：2023,50(5)